481 related articles for article (PubMed ID: 19170175)
41. [A case of leukemic IgD multiple myeloma complicating with abnormal plasma cells and M-protein in the pleural fluid].
Natori H; Yamaguchi T; Yasuda K; Egami K; Takii M; Yano T; Tanaka K; Kaji M; Shirozu K
Rinsho Ketsueki; 1982 Nov; 23(11):1733-40. PubMed ID: 6820089
[No Abstract] [Full Text] [Related]
42. [Multiple myeloma with D immunoglobulin].
Benchekroun L; Ouzzif Z; Bouabdillah M; Jaouhar N; Aoufir F; Aoufi F; Chabraoui L
Ann Biol Clin (Paris); 2011; 69(5):581-7. PubMed ID: 22008139
[TBL] [Abstract][Full Text] [Related]
43. [Diagnosis of multiple myeloma by demonstrating plasma cells in bronchoalveolar lavage].
Burkhardt O; Dickgreber NJ; Bühling F; Waldburg N; Merker HJ; Welte T
Dtsch Med Wochenschr; 2003 Sep; 128(38):1951-4. PubMed ID: 14502447
[TBL] [Abstract][Full Text] [Related]
44. Cytomorphology, clinicopathologic, and cytogenetics correlation of myelomatous effusion of serous cavities: A retrospective review.
Harbhajanka A; Brickman A; Park JW; Reddy VB; Bitterman P; Gattuso P
Diagn Cytopathol; 2016 Sep; 44(9):742-7. PubMed ID: 27434129
[TBL] [Abstract][Full Text] [Related]
45. [Drug-resistant multiple myeloma with high serum levels of lactate dehydrogenase and neutrophil infiltration in pleural effusion].
Kozawa M; Hata H; Kawaguchi T; Tsuji N; Mori S; Harada N; Nakahashi E; Sakata K; Matsuzaki H; Takatsuki K
Rinsho Ketsueki; 1994 Jan; 35(1):49-53. PubMed ID: 8139102
[TBL] [Abstract][Full Text] [Related]
46. Myelomatous pleural effusion with plasmablastic morphology and high genetic complexity as isolated extramedullary relapse.
Martín-Moro F; Roncancio A; Benito A; Talavera M; Villarrubia J; Blanchard MJ
Ann Hematol; 2020 Nov; 99(11):2705-2706. PubMed ID: 32458065
[No Abstract] [Full Text] [Related]
47. Dyspnea and pleural effusion as presenting clinical manifestations of multiple myeloma.
Neuman G; Denekamp Y
Isr Med Assoc J; 2009 Feb; 11(2):118-9. PubMed ID: 19432043
[No Abstract] [Full Text] [Related]
48. Myelomatous pleural effusion: A rare presentation of multiple myeloma.
Shameem M; Akhtar J; Khan NA; Baneen U; Bhargava R; Ahmed Z; Shahid M
Thorac Cancer; 2011 Aug; 2(3):128-130. PubMed ID: 27755834
[TBL] [Abstract][Full Text] [Related]
49. Mesenchymal stromal cells revert multiple myeloma cells to less differentiated phenotype by the combined activities of adhesive interactions and interleukin-6.
Dezorella N; Pevsner-Fischer M; Deutsch V; Kay S; Baron S; Stern R; Tavor S; Nagler A; Naparstek E; Zipori D; Katz BZ
Exp Cell Res; 2009 Jul; 315(11):1904-13. PubMed ID: 19328780
[TBL] [Abstract][Full Text] [Related]
50. The establishment of a human myeloma cell line elaborating lambda-light chain protein.
Niho Y; Shibuya T; Yamasaki K; Kimura N
Int J Cell Cloning; 1984 May; 2(3):161-72. PubMed ID: 6429256
[TBL] [Abstract][Full Text] [Related]
51. [A case of multiple myeloma (IgG, lambda-type)) with pathological plasmacytes and M-protein in the pleural fluid (author's transl)].
Fukushima K; Ishimi H; Tsutsui D; Morioka S; Nishimura Y; Tanaka T
Nihon Kyobu Shikkan Gakkai Zasshi; 1979 Jul; 17(7):415-20. PubMed ID: 119889
[No Abstract] [Full Text] [Related]
52. Flow Cytometry in Diagnosis of Myelomatous Pleural Effusion: A Case Report.
Arora P; Gupta SK; Mallik N; Mittal R; Sharma OD; Kumar L
Indian J Hematol Blood Transfus; 2016 Jun; 32(Suppl 1):138-42. PubMed ID: 27408376
[TBL] [Abstract][Full Text] [Related]
53. Refractory plasmablastic type myeloma with multiple extramedullary plasmacytomas and massive myelomatous effusion: remarkable response with a combination of thalidomide and dexamethasone.
Nakazato T; Suzuki K; Mihara A; Sanada Y; Kakimoto T
Intern Med; 2009; 48(20):1827-32. PubMed ID: 19834276
[TBL] [Abstract][Full Text] [Related]
54. [Amylase-producing multiple myeloma: a case report].
Mori M; Maruoka H; Nagai Y; Fujita H; Togami K; Tabata S; Kurata M; Matsushita A; Nagai K; Tanaka K; Yamashiro A; Takahashi T
Rinsho Ketsueki; 2007 Nov; 48(11):1484-8. PubMed ID: 18080506
[TBL] [Abstract][Full Text] [Related]
55. Myelomatous Pleural Effusion: Thoracoscopic Findings.
Nakashima K; Demura Y; Ishizuka T
Intern Med; 2024 Jun; 63(11):1667. PubMed ID: 37866914
[No Abstract] [Full Text] [Related]
56. Immunohistological analysis in diagnosis of plasma cell myeloma based on cytoplasmic kappa/lambda ratio of CD38-positive plasma cells.
Nakayama S; Yokote T; Hirata Y; Iwaki K; Akioka T; Miyoshi T; Nishiwaki U; Masuda Y; Hiraoka N; Takayama A; Nishimura Y; Tsuji M; Hanafusa T
Hematology; 2012 Nov; 17(6):317-20. PubMed ID: 23168070
[TBL] [Abstract][Full Text] [Related]
57. IgD myeloma indicated by plasma cells in the peripheral blood and massive pleural effusion.
Natori K; Izumi H; Nagase D; Fujimoto Y; Ishihara S; Kato M; Umeda M; Kuraishi Y
Ann Hematol; 2008 Jul; 87(7):587-9. PubMed ID: 18265984
[No Abstract] [Full Text] [Related]
58. IgD paraproteinemias.
Tichý M; Matĕja F; Urban P; Matuska M
Neoplasma; 1993; 40(1):59-61. PubMed ID: 8350950
[TBL] [Abstract][Full Text] [Related]
59. [Ectopic production of amylase by a non-producing type of multiple myeloma].
Wada H; Ohtsuki T; Sugihara T; Ata K; Hashimoto M; Yamada O; Yawata Y; Manabe T; Miyamoto K
Rinsho Ketsueki; 1990 Jul; 31(7):1022-7. PubMed ID: 1699005
[TBL] [Abstract][Full Text] [Related]
60. Morphologic heterogeneity and plasmablastic transformation in advanced plasmacytic/plasmablastic myeloma: a study of 35 serial bone marrow biopsies in 9 patients.
Paule B; Quillard J; Bennet P; Mariette X; Bisson M
Nouv Rev Fr Hematol (1978); 1989; 31(3):203-8. PubMed ID: 2616267
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
